Incidence risk of peripheral edema in cancer patients treated with PD-1/PD-L1 inhibitors: A PRISMA guideline systematic review and meta-analysis.
Yuan TianAlan HuangMei TianKaiyong WangQi DangCaiqing ZhangHongmei LiuJunyan ZhaoXiaowei YangChi ZhangLiang GuoFeng ChenPublished in: Medicine (2022)
The effect of PD-1/PD-L1 inhibitor on the risk of developing peripheral edema was weaker than that of chemotherapy, and the combination with chemotherapy slightly increased the incidence risk of developing peripheral edema without statistical significance.